Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
48M
-
Shares change
-
-2.79M
-
Total reported value, excl. options
-
$227M
-
Value change
-
-$34.7M
-
Put/Call ratio
-
0.54
-
Number of buys
-
62
-
Number of sells
-
-75
-
Price
-
$4.72
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2024
162 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2024.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48M shares
of 96M outstanding shares and own 50.04% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (5.63M shares), BlackRock, Inc. (4.79M shares), FRED ALGER MANAGEMENT, LLC (4.12M shares), T. Rowe Price Investment Management, Inc. (3.67M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.04M shares), Bain Capital Life Sciences Investors, LLC (2.76M shares), VANGUARD GROUP INC (2.55M shares), MILLENNIUM MANAGEMENT LLC (1.63M shares), VR Adviser, LLC (1.56M shares), and Sofinnova Investments, Inc. (1.53M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.